Redx Pharma to Be Acquired by Skye Bioscience, Concurrent $125 Million in Financings
August 18, 2026
August 18, 2026
PALO ALTO, California, Aug. 18 -- Cooley, a law firm, issued the following news release:
* * *
Redx Pharma to Be Acquired by Skye Bioscience, Concurrent $125 Million in Financings
Cooley advised Redx Pharma, a U.K. based, privately-held clinical-stage biotechnology company focused on developing novel, small molecule, targeted medicines for fibrotic disease, on its agreement to be acquired by Skye Bioscience, a clinical-stage biotechnology company. Upon comp . . .
* * *
Redx Pharma to Be Acquired by Skye Bioscience, Concurrent $125 Million in Financings
Cooley advised Redx Pharma, a U.K. based, privately-held clinical-stage biotechnology company focused on developing novel, small molecule, targeted medicines for fibrotic disease, on its agreement to be acquired by Skye Bioscience, a clinical-stage biotechnology company. Upon comp . . .